Close X
Wednesday, November 27, 2024
ADVT 
National

TransLink tests technology to sanitize air on buses

Darpan News Desk Translink, 06 Mar, 2021 12:23 AM
  • TransLink tests technology to sanitize air on buses

TransLink is testing a technology called photocatalytic oxidation (PCO) to sanitize the air and surfaces on board transit vehicles. The one-month pilot will begin March 6 on a 60-foot articulated bus and two double-decker buses.

PCO works by circulating low levels of hydrogen peroxide to kill pathogens like viruses. The technology, which has been tested for safe exposure levels, is already used in other sectors such as the hotel and restaurant industries.

The PCO process occurs in the HVAC system so customers will not be able to observe the process, but they may notice a subtle clean scent. The three buses will also have clear signage indicating that PCO is taking place.

“TransLink is continually looking at new and innovative technology to keep our customers on transit as safe as possible,” said CMBC President Michael McDaniel. “Photocatalytic oxidation is a safe technology and has been used in buildings owned by organizations like Google, Marriott, and Kennedy Space Center and we are optimistic that will it have a positive impact on our system.”

This testing period will determine PCO’s ability to effectively sanitize surfaces on transit and will work with peer agencies to validate the technology’s ability to sanitize air. Following the testing period, TransLink will analyze the data and determine if the technology meets the criteria for wider implementation.

TransLink has been building upon our Safe Operating Action Plan throughout the COVID-19 pandemic by researching, developing, and implementing practices to ensure transit remains as safe as possible. This includes being the first transit agency in North America to use bacteria killing copper surfaces on transit vehicles. We are going to great lengths to achieve our goal of making transit one of the safest public spaces.

Photo courtesy of Istock. 

MORE National ARTICLES

Ontario doctor Kulvinder Kaur Gill faces backlash from college of physicians over unprofessional social media posts

Ontario doctor Kulvinder Kaur Gill faces backlash from college of physicians over unprofessional social media posts
There was concern that Dr.Gill appeared to be "willfully spreading false and misleading information regarding COVID-19 that goes directly against the advice and recommendations of local, provincial, and federal medical/science and public health authorities."

Ontario doctor Kulvinder Kaur Gill faces backlash from college of physicians over unprofessional social media posts

New Westminster Police investigating serious assault

New Westminster Police investigating serious assault
The victim was transported to hospital, where she remains in critical condition. A nearby school was temporarily sheltering in place as a precaution while NWPD officers secured the scene.

New Westminster Police investigating serious assault

564 COVID19 cases for Thursday

564 COVID19 cases for Thursday
She says she expects the plan will be finalized around March 18, in the meantime the initial supply will be used to address ongoing outbreaks that are leading to rapidly increasing case numbers in some communities.

564 COVID19 cases for Thursday

One of Canada’s most wanted arrested by Coquitlam RCMP

One of Canada’s most wanted arrested by Coquitlam RCMP
Police attended the residence and through the investigation identified Amin Yussuf, who has four outstanding warrants from a homicide that occurred in Edmonton on March 24, 2019.

One of Canada’s most wanted arrested by Coquitlam RCMP

B.C. expands small business recovery grant program

B.C. expands small business recovery grant program
The province has also extended the deadline for businesses to apply from the end of this month to Aug. 31, or until all the money has been spent.

B.C. expands small business recovery grant program

Vaccine efficacy is being misinterpreted: experts

Vaccine efficacy is being misinterpreted: experts
Many of those who did become infected after getting a vaccine in the trials experienced mild illness, according to the data, which Chakrabarti says isn't a big concern.

Vaccine efficacy is being misinterpreted: experts